Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity

…, A Meyer, Y Uzunhan, A Masseau, S Dubucquoi… - Autoimmunity …, 2012 - Elsevier
The clinical phenotype and evolution of antisynthetase syndrome (ASS) are heterogeneous.
This study was therefore undertaken to identify subgroups of ASS patients with similar …

[HTML][HTML] Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

…, M Titecat, P Bortolotti, L Martinez, S Dubucquoi… - PloS one, 2014 - journals.plos.org
One year after the occurrence of the first case of infection by the Middle East Respiratory
Syndrome coronavirus (MERS-CoV) there is no clear consensus on the best treatment to …

Prevalence of anti–RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta‐analysis

…, PY Hatron, D Launay, S Dubucquoi - Arthritis & …, 2014 - Wiley Online Library
Objective Studies assessing the prevalence of anti–RNA polymerase III (anti–RNAP III)
antibodies in systemic sclerosis (SSc) have yielded a wide range of results. The aim of the …

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients

…, E Hachulla, T Stojkovic, D Ferriby, S Dubucquoi… - Medicine, 2004 - journals.lww.com
Neurologic involvement occurs in approximately 20% of patients with primary Sjögren
syndrome (SS). However, the diagnosis of SS with neurologic involvement is sometimes …

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.

S Dubucquoi, P Desreumaux, A Janin, O Klein… - The Journal of …, 1994 - rupress.org
Interleukin 5 (IL-5) is the main factor that promotes the terminal differentiation of eosinophil
progenitors (as indicated by colony formation assays), and enhances the effector capacity of …

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

S Dubucquoi, E Solau-Gervais, D Lefranc… - Annals of the …, 2004 - ard.bmj.com
Background: Anti-filaggrin antibodies (AFA) are among the most specific antibodies for
rheumatoid arthritis, so procedures for their detection should be included in early biological …

The spectrum of FIP1L1-PDGFRA-associated chronic eosinophilic leukemia: new insights based on a survey of 44 cases

…, M Hamidou, O Lidove, A Baruchel, S Dubucquoi… - Medicine, 2013 - journals.lww.com
Imatinib is the treatment of choice for FIP1L1/PDGFRA (F/P)-associated chronic eosinophilic
leukemia (F/P+ CEL), but its optimal dosing, duration, and possibility of discontinuation are …

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients

…, M Lambert, E Hachulla, M Samor, S Dubucquoi… - Lupus, 2008 - journals.sagepub.com
One hundred and three consecutive asymptomatic anti-phospholipid (aPL) antibody-positive
carriers, taking aspirin (n= 75) or not (n= 28), were studied retrospectively to determine …

Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

S Dubucquoi, A Janin, O Klein, P Desreumaux… - Gut, 1995 - gut.bmj.com
Endoscopic recurrences after radical surgery for Crohn's disease are useful for studying the
pathogenesis of initial lesions of Crohn's disease. Factors predisposing to recurrence are …

Altered B lymphocyte homeostasis and functions in systemic sclerosis

…, P Vermersch, M Labalette, D Launay, S Dubucquoi - Autoimmunity …, 2018 - Elsevier
Beyond the production of autoantibodies, B-cells are thought to play a role in systemic
sclerosis (SSc) by secreting proinflammatory/profibrotic cytokines. B-cells are a …